CN102335336A - 一种治疗红斑狼疮的中药 - Google Patents
一种治疗红斑狼疮的中药 Download PDFInfo
- Publication number
- CN102335336A CN102335336A CN2010102373234A CN201010237323A CN102335336A CN 102335336 A CN102335336 A CN 102335336A CN 2010102373234 A CN2010102373234 A CN 2010102373234A CN 201010237323 A CN201010237323 A CN 201010237323A CN 102335336 A CN102335336 A CN 102335336A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- rhizoma
- traditional chinese
- caulis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 206010025135 Lupus erythematosus Diseases 0.000 title claims abstract description 16
- 241000209020 Cornus Species 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 7
- 235000005035 ginseng Nutrition 0.000 claims abstract description 7
- 210000000582 Semen Anatomy 0.000 claims description 10
- 241000208340 Araliaceae Species 0.000 claims description 6
- 241000756943 Codonopsis Species 0.000 claims description 6
- 241000237903 Hirudo Species 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 9
- 231100000486 side effect Toxicity 0.000 abstract description 3
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- QMGVPVSNSZLJIA-XBPPHNHDSA-N (4aR,5aS,8aR,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one Chemical compound C1([C@H]2[C@H]3C4)N(C=5C6=CC=CC=5)C(=O)CC2OCC=C3CN2[C@@H]4[C@]16CC2 QMGVPVSNSZLJIA-XBPPHNHDSA-N 0.000 abstract 1
- 229940107666 ASTRAGALUS ROOT Drugs 0.000 abstract 1
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 240000001992 Angelica archangelica Species 0.000 abstract 1
- 235000015700 Artemisia abrotanum Nutrition 0.000 abstract 1
- 240000001694 Artemisia abrotanum Species 0.000 abstract 1
- 241000132011 Atractylodes lancea Species 0.000 abstract 1
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 235000002723 Dioscorea alata Nutrition 0.000 abstract 1
- 235000007056 Dioscorea composita Nutrition 0.000 abstract 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 abstract 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 abstract 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 abstract 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 abstract 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 240000003594 Eclipta prostrata Species 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 240000005389 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241001479541 Lithospermum erythrorhizon Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 240000002645 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 240000004678 Panax pseudoginseng Species 0.000 abstract 1
- 240000001754 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000007801 Strychnos nux vomica Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 235000006350 apichu Nutrition 0.000 abstract 1
- 235000009242 dandelion Nutrition 0.000 abstract 1
- 235000014079 dandelion Nutrition 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000004977 physiological function Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 210000004369 Blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 210000003734 Kidney Anatomy 0.000 description 10
- 210000004185 Liver Anatomy 0.000 description 9
- 210000000952 Spleen Anatomy 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 230000001717 pathogenic Effects 0.000 description 6
- 231100000614 Poison Toxicity 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003390 Chinese drug Substances 0.000 description 3
- 206010040882 Skin lesion Diseases 0.000 description 3
- 229940079593 drugs Drugs 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 210000000056 organs Anatomy 0.000 description 3
- 230000001737 promoting Effects 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 210000001124 Body Fluids Anatomy 0.000 description 2
- 210000000988 Bone and Bones Anatomy 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000004921 Cutaneous Lupus Erythematosus Diseases 0.000 description 2
- 208000006926 Discoid Lupus Erythematosus Diseases 0.000 description 2
- 210000004072 Lung Anatomy 0.000 description 2
- 208000006802 Lupus Erythematosus Panniculitis Diseases 0.000 description 2
- 210000003205 Muscles Anatomy 0.000 description 2
- 206010072736 Rheumatic disease Diseases 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N Strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000002605 anti-dotal Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000002522 swelling Effects 0.000 description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 230000002936 tranquilizing Effects 0.000 description 2
- 210000000577 Adipose Tissue Anatomy 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010003816 Autoimmune disease Diseases 0.000 description 1
- 210000000601 Blood Cells Anatomy 0.000 description 1
- 210000001217 Buttocks Anatomy 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 210000000232 Gallbladder Anatomy 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 210000000987 Immune System Anatomy 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 208000005777 Lupus Nephritis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000008425 Protein Deficiency Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 229940069514 Rhubarb preparation Drugs 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 206010068760 Ulcers Diseases 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 230000001070 adhesive Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 201000004384 alopecia Diseases 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 230000000078 anti-malarial Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000001914 calming Effects 0.000 description 1
- 230000002490 cerebral Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressed Effects 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001861 immunosuppresant Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003902 lesions Effects 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 231100000516 lung damage Toxicity 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drugs Drugs 0.000 description 1
- 230000001473 noxious Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000002616 plasmapheresis Methods 0.000 description 1
- 230000025627 positive regulation of urine volume Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Abstract
本发明公开了一种治疗红斑狼疮的中药,其特征是由下列重量配比的原料制成的:党参、人参、丹参、黄芪、黄连、黄芩、黄精、鸡血藤、忍冬藤、络石藤、水牛角、羚羊角、茯苓、白术、白花蛇舌草、连翘、制马钱子、甘草、旱莲草、当归、紫草、栀子、地骨皮、山药、川断、青蒿、泽泻、枸杞子、女贞子、怀牛膝、蒲公英、牛黄、水蛭按一定比例配制而成的。本发明从调理人体生理机能为出发点,治疗效果好,无毒副作用,标本兼治。
Description
一种治疗红斑狼疮的中药
技术领域
[0001] 本发明涉及一种中药,特别是一种治疗法红斑狼疮的中药。 背景技术
[0002] 红斑狼疮根据其病情的变化,一般可分为以下几种:一是盘状红斑狼疮,主要侵犯皮肤,是红斑狼疮中最轻的类型。皮肤损害初起时为一片或数片鲜红色斑,绿豆至黄豆大, 表面有粘着性鳞屑,以后逐渐扩大,呈圆形或不规则形,边缘色素明显加深,略高于中心,中央色淡,可萎缩、低洼,整个皮损呈盘状(故名盘状红斑狼疮)。二是深部红斑狼疮,又称狼疮性脂膜炎,同样是中间类型的红斑狼疮,皮肤损害为结节或斑块,位于真皮深层或皮下脂肪组织,其大小、数目不定,表面肤色正常或淡红色,质地坚实,无移动性。损害可发生于任何部位,最常见于颊部、臀部、臂部,其次为小腿和胸部。三是系统性红斑狼疮,红斑狼疮是一种自身免疫性疾病,能累及身体多系统、多器官,在患者的血液和器官中能找到多种自身抗体。红斑狼疮常常会有许多症状,如:发热、红斑皮疹、粘膜溃疡和脱发、关节疼痛、血液细胞减少、心脏、肺损害、狼疮性肾炎、脑损害等等。红斑狼疮的病理形态因病情、病变部位而异,变化较大。一般认为它与遗传、感染、内分泌及环境等因素有关。目前,治疗红斑狼疮的方法有多种,西医一般采用非留体类抗炎药、抗疟药、糖皮质激素、免疫抑制剂等药物治疗, 西医治疗副作用大,治标不治本,不易根治。也有采用血浆交换疗法,其费用较高。中国国家中医药管理局发布了红蝴蝶斑辨证标准,辨证分为六个症型,分别为热毒炽盛型、阴虚内热型、肝肾阴虚型、邪热伤肝型、脾肾阴虚型及风湿热痹型,大致包括了系统性红斑狼疮的急性活动期,稳定期及脏器损伤的一些情况,根据各症型的临床表现,分别选用不同的治疗方剂及药物。根据红斑狼疮病的变化规律,抓住该病的主要病机,针对病机设定治疗方剂, 以一方统治,其中有的用滋阴补肾法,有的用活血化瘀法,有的用解毒清热法,有的用祛风除痹法等。中医疗法一般采用复方金荞片、三蛇糖浆、五倍子和蜜陀僧散,红花制剂、丹参制剂、大黄制剂等药物。
发明内容
[0003] 本发明的目的是提供一种新的用于治疗红斑狼疮的中药,该中药从调理人体生理机能为出发点,治疗效果好,无毒副作用,标本兼治。
[0004] 为实现本发明的上述目的所采用的技术方案是:一种治疗红斑狼疮的中药,其特征是由下列重量配比的原料制成的:党参10-12、人参10-12、丹参10-12、黄芪10-15、黄连8-10、黄芩10-15、黄精10-15、鸡血藤8_10、忍冬藤8_10、络石藤8_10、水牛角10-15、羚羊角10-15、茯苓10-15、白术10-15、白花蛇舌草10-12、连翘10-12、制马钱子10-12、甘草 10-15、旱莲草10-12、当归10-15、紫草10-12、桅子10-12、地骨皮10-12、山药10-15、川断 10-12、青蒿10-12、泽泻10-12、枸杞子10-15、女贞子10-12、怀牛膝10-12、蒲公英10-12、 牛黄10-12、水蛭8-10。
[0005] 本发明的加工方法为按常规方法加工成药液等中药剂。[0006] 服用方法,每日三次,每次50ml。
[0007] 本发明是针对红斑狼疮患者一般症状,即肝郁化热,心火内炽,血热成瘀等特点, 治疗以补中益气,清热解毒,通络止痛,补肾养肝,健脾补肾,补心安神为主,方中党参、黄芪补中益气,生津养血,可激发人体的免疫系统,还可降低疼痛因子对肌肉骨骼的刺激;茯苓、白术健脾利湿,消肿利关节;白花蛇舌草、连翘有清热解毒,透邪外出之功;丹参活血祛瘀生新;鸡血藤、络石藤祛风通络、凉血消肿;忍冬藤可清经络中的风湿热邪;制马钱子与甘草合用,可增加马钱子的通络散瘀、消肿定痛之效,又可减低其毒副作用;制马钱子中的士的宁碱与忍冬藤、鸡血藤中所含的藤素碱,均可减轻关节滑膜的痛刺激,有通利关节的作用;黄连、黄芩具有泻火解毒的功效;黄精具有补气养阴,健脾,润肺,益肾的功效;枸杞具有补肾益精,养肝明目,补血安神的功效;人参则具有大补元气,固脱生津,安神的功效;水牛角具有清热解毒,善清血热的功效;羚羊角具有平肝熄风,清热镇惊,凉血解毒,散血解毒的功效;旱莲草具有滋补肝肾,凉血止血的功效;当归具有补血活血的功效;紫草、地骨皮具有凉血,活血,清热,解毒的功效;桅子泻火除烦,凉血解毒,清利湿热;山药有健脾、除湿、补气、益肺、固肾、益精的功效;川断补肝肾、强筋骨、调血脉、续折伤、止崩漏;青蒿清透虚热,凉血除蒸;泽泻利水,渗湿,泄热;女贞子补益肝肾;清虚热;怀牛膝补肝肾,强筋骨, 逐瘀通经,引血下行;蒲公英清热解毒,消痈散结;牛黄清心,化痰,利胆,镇惊;水蛭具有破血,逐瘀的功效,本发明将这些药物有机地配合在一起所制成的中药,经临床表明,组方合理、标本兼治、疗效显著、清热解毒、凉血祛瘀、健脾消积、无毒副作用,迅速祛斑。
具体实施方式
[0008] 下面结合具体实施的例子对本发明做进一步详细的描述。
[0009] 1、称取党参10g、人参10g、丹参10g、黄芪10g、黄连Sg、黄芩10g、黄精10g、鸡血藤8g、忍冬藤8g、络石藤8g、水牛角10g、羚羊角10g、茯苓10g、白术10g、白花蛇舌草10g、 连翘10g、制马钱子10g、甘草10g、旱莲草10g、当归10g、紫草10g、桅子10g、地骨皮10g、山药10g、川断10g、青蒿10g、泽泻10g、枸杞子10g、女贞子10g、怀牛膝10g、蒲公英10g、牛黄 10g、水蛭Sg。按常规方法加工成药液等中药剂型,分装即可。
[0010] 2、称取党参12、人参12g、丹参12g、黄芪15g、黄连10g、黄芩15g、黄精15g、鸡血藤 10g、忍冬藤log、络石藤10g、水牛角15g、羚羊角15g、茯苓15g、白术15g、白花蛇舌草12g、 连翘12g、制马钱子12g、甘草15g、旱莲草12g、当归15g、紫草12g、桅子12g、地骨皮12g、山药15g、川断12g、青蒿12g、泽泻12g、枸杞子15g、女贞子12g、怀牛膝12g、蒲公英12g、牛黄 12g、水蛭10g。按常规方法加工成药液等中药剂型,分装即可。
[0011] 3、称取党参11、人参llg、丹参llg、黄芪13g、黄连9g、黄芩13g、黄精13g、鸡血藤 9g、忍冬藤9g、络石藤9g、水牛角13g、羚羊角13g、茯苓13g、白术13g、白花蛇舌草llg、连翘llg、制马钱子llg、甘草13g、旱莲草llg、当归13g、紫草llg、桅子llg、地骨皮llg、山药 135g、川断llg、青蒿llg、泽泻llg、枸杞子13g、女贞子llg、怀牛膝llg、蒲公英llg、牛黄 llg、水蛭9g。按常规方法加工成药液等中药剂型,分装即可。
Claims (1)
1. 一种治疗红斑狼疮的中药,其特征是由下列重量配比的原料制成的:党参10-12、 人参10-12、丹参10-12、黄芪10-15、黄连8-10、黄芩10-15、黄精10-15、鸡血藤8-10、忍冬藤8-10、络石藤8-10、水牛角10-15、羚羊角10-15、茯苓10-15、白术10-15、白花蛇舌草 10-12、连翘10-12、制马钱子10-12、甘草10-15、早莲草10-12、当归10-15、紫草10-12、桅子10-12、地骨皮10-12、山药10-15、川断10-12、青蒿10-12、泽泻10-12、枸杞子10-15、女贞子10-12、怀牛膝10-12、蒲公英10-12、牛黄10-12、水蛭8_10。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102373234A CN102335336A (zh) | 2010-07-22 | 2010-07-22 | 一种治疗红斑狼疮的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102373234A CN102335336A (zh) | 2010-07-22 | 2010-07-22 | 一种治疗红斑狼疮的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102335336A true CN102335336A (zh) | 2012-02-01 |
Family
ID=45511436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102373234A Pending CN102335336A (zh) | 2010-07-22 | 2010-07-22 | 一种治疗红斑狼疮的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102335336A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552748A (zh) * | 2012-03-06 | 2012-07-11 | 孙喜灵 | 一种具有美容养颜作用的中药 |
CN103599261A (zh) * | 2013-11-28 | 2014-02-26 | 谢宗祥 | 一种治疗红斑狼疮的中药 |
CN105327128A (zh) * | 2015-10-26 | 2016-02-17 | 卢鹏 | 一种用于治疗毒热侵肤的中药 |
CN106266306A (zh) * | 2016-08-31 | 2017-01-04 | 李海峰 | 治疗脚癣的中药组合物 |
-
2010
- 2010-07-22 CN CN2010102373234A patent/CN102335336A/zh active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552748A (zh) * | 2012-03-06 | 2012-07-11 | 孙喜灵 | 一种具有美容养颜作用的中药 |
CN102552748B (zh) * | 2012-03-06 | 2013-06-26 | 孙喜灵 | 一种具有美容养颜作用的中药 |
CN103599261A (zh) * | 2013-11-28 | 2014-02-26 | 谢宗祥 | 一种治疗红斑狼疮的中药 |
CN105327128A (zh) * | 2015-10-26 | 2016-02-17 | 卢鹏 | 一种用于治疗毒热侵肤的中药 |
CN106266306A (zh) * | 2016-08-31 | 2017-01-04 | 李海峰 | 治疗脚癣的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1562160A (zh) | 治疗乙型肝炎并发症组方药物 | |
CN100496586C (zh) | 治疗骨质增生和腰椎间盘突出症的药酒 | |
CN103341004B (zh) | 一种治疗月经后期的中药组合物 | |
CN1475229A (zh) | 抗疲劳复方中药方剂及其制备方法 | |
CN103705682B (zh) | 一种治疗风湿腰痛的药物 | |
CN1131053C (zh) | 一种治疗糖尿病的中药 | |
CN103028090B (zh) | 一种治疗气虚的中药组合物 | |
CN1160559A (zh) | 乙肝化毒丸 | |
CN102068661A (zh) | 一种治疗女性血淤、血虚、脉沉细型痛经的中药配方 | |
CN103721190A (zh) | 一种囊肿型痤疮合剂 | |
CN104001035A (zh) | 一种治疗二型糖尿病花粉葛根中药制剂 | |
CN101658657B (zh) | 一种用于治疗慢性胆囊炎的药物 | |
CN102335336A (zh) | 一种治疗红斑狼疮的中药 | |
CN102988616B (zh) | 一种治疗贫血的中药组合物 | |
CN104288496A (zh) | 一种治疗便秘的中药组合物 | |
CN102283956A (zh) | 一种治疗慢性肝炎的内服药物 | |
CN1317021C (zh) | 一种蠲痺定痛的中药制剂 | |
CN1270765C (zh) | 治疗感冒的药酒或药液 | |
CN103599496A (zh) | 一种治疗慢性胃炎的中药 | |
CN103623385B (zh) | 一种治疗口腔溃疡的中药 | |
CN103127351B (zh) | 一种治疗月经提前中药 | |
CN104906333A (zh) | 一种增强心肺功能的中药组合物 | |
CN103611100A (zh) | 一种治疗牙疼病的中药 | |
CN103893724A (zh) | 治疗妇女肝郁脾虚型特发性水肿的中药组合物 | |
CN103800840A (zh) | 一种治疗颈椎病的中药口服液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120201 |